|
ANKRD5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.025910E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.123770E-01 |
| Normal-vs-Stage2 |
4.725400E-01 |
| Normal-vs-Stage3 |
1.128440E-01 |
| Normal-vs-Stage4 |
8.841600E-01 |
| Stage1-vs-Stage2 |
9.512200E-01 |
| Stage1-vs-Stage3 |
3.463000E-01 |
| Stage1-vs-Stage4 |
6.576600E-01 |
| Stage2-vs-Stage3 |
4.364600E-01 |
| Stage2-vs-Stage4 |
6.910000E-01 |
| Stage3-vs-Stage4 |
2.168800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.129740E-02 |
| Normal-vs-AfricanAmerican |
3.732800E-01 |
| Normal-vs-Asian |
4.318400E-01 |
| Caucasian-vs-AfricanAmerican |
2.491200E-01 |
| Caucasian-vs-Asian |
7.875800E-01 |
| AfricanAmerican-vs-Asian |
9.394000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.390780E-01 |
| Normal-vs-Female |
1.704190E-03 |
| Male-vs-Female |
2.125500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.268400E-01 |
| Normal-vs-Extreme_Weight |
7.943200E-01 |
| Normal-vs-Obese |
3.565500E-02 |
| Normal-vs-Extreme_Obese |
6.639600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.553600E-01 |
| Normal_Weight-vs-Obese |
3.817000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.696000E-01 |
| Extreme_Weight-vs-Obese |
1.005040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.481400E-01 |
| Obese-vs-Extreme_Obese |
6.077600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.221700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.820600E-03 |
| Normal-vs-Age(61-80Yrs) |
2.260400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.896400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.516600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.149800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.561900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.191600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.888100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.153000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.836400E-02 |
| Normal-VS-Type2 PRCC |
4.117600E-01 |
| Normal-VS-KIRP CIMP |
4.849700E-02 |
| Normal-VS-Unclassified PRCC |
2.816700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.390000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.015000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.118500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.004400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.598410E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.831600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.834600E-01 |
| Normal-vs-N1 |
4.578400E-02 |
| Normal-vs-N2 |
7.373800E-01 |
| N0-vs-N1 |
1.032160E-01 |
| N0-vs-N2 |
8.184000E-01 |
| N1-vs-N2 |
2.821800E-01 |
|
|
